Related Experiment Video
Updated: May 24, 2026

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Atrial fibrillation: the beat is faster than the answers
1Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. szcze001@mc.duke.edu
Insights
Patients with end-stage renal disease (ESRD) have higher rates of atrial fibrillation. This commentary highlights significant knowledge gaps in treating atrial fibrillation in this vulnerable ESRD population.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Atrial fibrillation (AF) is more prevalent in end-stage renal disease (ESRD) patients compared to the general population.
- Recent advancements in AF treatment exist for the general population, but data for ESRD patients are scarce.
Purpose of the Study:
- To identify and explore the knowledge gaps in treating atrial fibrillation (AF) specifically within the end-stage renal disease (ESRD) patient population.
- To highlight the need for further research into effective AF management strategies for ESRD patients.
Main Methods:
- This is a commentary, not an original research study.
- It involves a review and synthesis of existing literature and clinical understanding regarding AF in ESRD.
Main Results:
- Significant gaps in knowledge exist regarding the optimal treatment of atrial fibrillation in ESRD patients.
- The unique physiological challenges and comorbidities in ESRD complicate treatment decisions.
Conclusions:
- There is a critical need for more research to establish evidence-based guidelines for managing atrial fibrillation in the end-stage renal disease population.
- Addressing these knowledge gaps is essential for improving outcomes in this vulnerable patient group.
Abstract:
The prevalence of atrial fibrillation is much greater among persons with end-stage renal disease (ESRD) than among the general population. While significant advances have been made recently in the treatment of atrial fibrillation in the general population, we know very little about the treatment of atrial fibrillation among those with ESRD. This Commentary explores gaps in our knowledge of how to treat this vulnerable and sick population.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
The Cardiac Cycle
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and empty blood into the...

